最新ニュース Outset Medical (NASDAQ:OM) 株価情報

Outset Medical

Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

Outset Medical Inc

MANTRA DAO

Grupo Aeroportuario del Centro Norte S.A.B. de C.V. - American Depositary Shares each representing 8 Series B shares

Grupo Aeroportuario del Centro Norte SAB de CV

Omagine Inc

Tidal Trust III VistaShares Target 15 Berkshire Select Income ETF

Origin Protocol - United States Dollar

Omnicom Group Inc

Old Market Capital Corporation - Common Stock

Old Market Capital Corp

Omnicell Inc

ORMAND INDUSTRIES INC by Ormand Industries, Inc.

Ormand Inds Inc

Omeros Corp

Odyssey Marine Exploration, Inc. - Common Stock

Odyssey Marine Exploration Inc

OneMain Holdings Inc

Invesco Exchange-Traded Self-Indexed Fund Trust Invesco Russell 1000 Dynamic Multifactor ETF

Invesco Exchange-Traded Self-Indexed Fund Trust Invesco Russell 2000 Dynamic Multifactor ETF

OmiseGO - United States Dollar

OMEGA THERAPEUTICS INC by Omega Therapeutics, Inc.

Omega Therapeutics Inc

OMAI GOLD MINES CORP by OMAI GOLD MINES CORP.

Omai Gold Mines Corp

OMEGA OIL NL by OMEGA OIL NL

OMEGA PAC RES INC by Omega Pacific Resources Inc.

Omega Pacific Resources Inc

Ohmyhome Ltd

Omni Health Inc

OM HOLDINGS INTL INC by OM Holdings International, Inc.

Om Holdings International Inc

OM Holdings Ltd

Owens & Minor Inc

Singular Genomic Systems Inc COM NEW

Omid Holdings Inc

oOh media Ltd

OMNIMMUNE HOLDINGS INC by Omnimmune Holdings, Inc.

Omnimmune Holdings Inc

OMINECA MINING & MTLS ORD by Omineca Mining & Metals Ltd.

Omineca Mining and Metals Ltd

OMN - United States Dollar

Omni Network - United States Dollar

Omphalos Corp

OMNIQ Corp

OMRON Corp

Orthometrix Inc

OMS Energy Technologies Inc. - Ordinary Shares

OMS Energy Technologies Inc

OMNITEK ENGINEERING CORP by Omnitek Engineering Corp.

OmniTek Engineering Corp

Omni Ventures Inc

OMV AG

Omnia Wellness Inc

Osisko Metals Inc

News

Damon To Forego Right To Appeal Nasdaq Delisting Determination; To Resume Trading On Nasdaq For One Day And Then To Trade On OTC Markets

WIIM

QVCGA

QVC Group shares are trading lower after the company's board approved a 1-for-50 reverse stock split.

JP Morgan analyst Cory Carpenter maintains Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) with a Overweight and raises the price target from $225 to $250.

Price Target

Analyst Ratings

TTWO

JP Morgan Maintains Overweight on Take-Two Interactive, Raises Price Target to $250

As of May 16, 2025, three stocks in the consumer discretionary sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="ps://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Leggett &amp; Platt Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>)</h3>
<ul class="wp-block-list">
<li>On April 28, Leggett &amp; Platt reported better-than-expected first-quarter EPS results and raised its FY25 EPS guidance. President and CEO Karl Glassman commented, &#8220;We are pleased to report better than anticipated first quarter earnings. Our earnings improvement is a testament to the excellent execution of our restructuring plan and operational efficiency improvement initiatives, as well as disciplined cost management.&#8221; The company's stock jumped around 46% over the past month and has a 52-week high of $14.24.</li>
<li>RSI Value: 70.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>LEG Price Action: Shares of Leggett &amp; Platt gained 0.8% to close at $9.55 on Thursday.</li>
<li>Edge Stock Ratings: 23.09 Momentum score with Value at 14.19. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/leg"><img loading="lazy" decoding="async" width="487" height="180" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16052501/image-195.png" alt="" class="wp-image-917661" style="width:387px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16052501/image-195.png 487w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16052501/image-195-300x111.png 300w" sizes="(max-width: 487px) 100vw, 487px" /></a></figure>
<h3 class="wp-block-heading">Fossil Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSL#NASDAQ">FOSL</a>)</h3>
<ul class="wp-block-list">
<li>On May 14, Fossil Group reported a year-over-year increase in first-quarter adjusted EPS results. &#8220;We are pleased to deliver another quarter of progress under our turnaround plan,&#8221; said Franco Fogliato, CEO. The company's stock gained around 59% over the past month and <a href="https://www.benzinga.com/quote/FOSL">has a 52-week high</a> of $2.61.</li>
<li>RSI Value: 80.2</li>
<li>FOSL Price Action: Shares of Fossil gained 15.9% to close at $1.46 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Laureate Education Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAUR#NASDAQ">LAUR</a>)</h3>
<ul class="wp-block-list">
<li>On May 1, Laureate Education reported better-than-expected first-quarter financial results and raised its FY25 sales guidance. The company's stock gained around 17% over the past month and has a <a href="https://www.benzinga.com/quote/LAUR">52-week high</a> of $23.61.</li>
<li>RSI Value: 72.5</li>
<li>LAUR Price Action: Shares of Laureate Education gained 0.7% to close at $22.64 on Thursday.</li>
</ul>
Curious about other BZ Edge Rankings? Click here to discover <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">how similar stocks measure up</a>. 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

FOSL

LAUR

Top 3 Consumer Stocks That May Fall Off A Cliff In Q2

TOPW

Top Win International shares are trading higher after the company announced it launched a digital assets treasury strategy to participate in Asia's growing web3 ecosystem.

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">131.0900</td>
<td align="right">0.63</td>
<td align="right">0.48</td>
<td>35.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">81.3200</td>
<td align="right">0.33</td>
<td align="right">0.40</td>
<td>2.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">86.4899</td>
<td align="right">0.32</td>
<td align="right">0.37</td>
<td>603</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">216.4300</td>
<td align="right">0.80</td>
<td align="right">0.37</td>
<td>4.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">85.8800</td>
<td align="right">0.27</td>
<td align="right">0.31</td>
<td>67.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">142.6000</td>
<td align="right">0.44</td>
<td align="right">0.30</td>
<td>2.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">51.3500</td>
<td align="right">0.07</td>
<td align="right">0.13</td>
<td>69.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">101.2200</td>
<td align="right">0.13</td>
<td align="right">0.12</td>
<td>28.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">234.7500</td>
<td align="right">0.30</td>
<td align="right">0.12</td>
<td>120.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.2000</td>
<td align="right">0.06</td>
<td align="right">0.07</td>
<td>11.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">41.5200</td>
<td align="right">0.03</td>
<td align="right">0.07</td>
<td>1.0K</td>
</tr>
</tbody>
</table>
No loser in today's Pre-market session. 
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Movers

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For May 16, 2025

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.
Shares of Globant S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected first-quarter financial results, issued second-quarter guidance below estimates, and <a href="https://www.benzinga.com/quote/GLOB">cut its FY25 guidance</a>.
Globant reported quarterly earnings of $1.50 per share which missed the analyst consensus estimate of $1.58 per share. The company reported quarterly sales of $611.09 million which missed the analyst consensus estimate of $621.38 million.
Globant shares dipped 26.2% to $98.00 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) dipped 22.1% to $45.52 in pre-market trading after the company issued FY26 sales guidance below estimates.</li>
<li>Travere Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) declined 15.2% to $17.94 in pre-market trading. The company announced that the FDA accepted its supplemental New Drug Application for traditional approval of FILSPARI for the treatment of focal segmental glomerulosclerosis.</li>
<li>Arrive AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAI#NASDAQ">ARAI</a>) fell 13.2% to $11.50 in pre-market trading after dipping 67% on Thursday.</li>
<li>BRF S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRFS#NYSE">BRFS</a>) dropped 11.1% to $3.19 in pre-market trading after gaining 3% on Thursday.</li>
<li>Lithium Americas Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAC#NYSE">LAC</a>) dipped 10.8% to $2.82 in pre-market trading as the company filed for mixed shelf of up to $1.0 billion.</li>
<li>KULR Technology Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NASDAQ">KULR</a>) fell 10.1% to $1.33 in pre-market trading after the company reported first-quarter financial results and missed its EPS and revenue estimates.</li>
<li>Applied Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) fell 5.8% to $164.65 in pre-market trading. Applied Materials reported better-than-expected earnings for its second quarter, while sales missed estimates. Applied Materials said it expects third-quarter revenue of $7.2 billion, plus or minus $500 million, versus estimates of $7.19 billion. The company expects third-quarter adjusted earnings to be between $2.15 and $2.55 per share, versus estimates of $2.32 per share.</li>
<li>Take-Two Interactive Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) fell 3.7% to $223.68 in pre-market trading. Take-Two reported fourth-quarter net bookings of $1.58 billion, up 17% year-over-year. The total beat a Street consensus estimate of $1.55 billion according to data from Benzinga Pro. The company said it expects first quarter net bookings to be in a range of $1.25 billion to $1.30 billion. The company guides for full fiscal-year net bookings to be in a range of $5.90 billion to $6.00 billion.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

AMAT

ARAI

BRFS

DOCS

GLOB

KULR

TVTX

Globant, Doximity, Applied Materials And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Bon Natural Life Limited shares are trading higher after the company announced a cooperation agreement with Beijing's Huahai Keyuan, who will serve as an exclusive sales partner.

The deal expands the current slate with new co-produced shows and continues the distribution of Bloomberg's full catalog of podcasts including newly launched "Levittown" and "Everybody's Business"

IHRT

iHeartMedia Extends Multiyear Podcast Partnership With Bloomberg Media

JP Morgan analyst Mark Strouse maintains GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Overweight and raises the price target from $430 to $460.

JP Morgan Maintains Overweight on GE Vernova, Raises Price Target to $460

<a href="https://www.coinbase.com/blog/coinbase-partners-with-webull-pay-to-power-crypto-experience" title="https://www.coinbase.com/blog/coinbase-partners-with-webull-pay-to-power-crypto-experience">https://www.coinbase.com/blog/coinbase-partners-with-webull-pay-to-power-crypto-experience</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

BULL

COIN

Coinbase Partners with Webull Pay to Power Crypto Experience

Occidental And ADNOC's XRG Evaluate Joint Venture To Develop Direct Air Capture Hub

SMCI

Super Micro Computer Enters Into Strategic Partnership Under MOU With DataVolt To Build Hyperscale AI Campuses Initially In Kingdom Of Saudi Arabia

INZY

Inozyme shares are trading higher after the company announced BioMarin will acquire the company for about $270 million.

JP Morgan analyst Harlan Sur maintains Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) with a Overweight and lowers the price target from $240 to $210.

JP Morgan Maintains Overweight on Applied Mat, Lowers Price Target to $210

- Treatment with ELEVIDYS for Duchenne muscular dystrophy resulted in mean protein expression of 93.87% as measured by western blot in study participants (n=6)
- Safety profile consistent with prior studies of ELEVIDYS and real-world experience

Biotech

General

SRPT

Sarepta Therapeutics Shares Safety Results From ENDEAVOR Study In 2-Year-Old Participants

SoFi's Rising Stars Program Provides Post-Secondary Students with Financial Skills and Resources They Need to Succeed: Financial Education, 1:1 Coaching, Grants, and Resources to Start Investing Early
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sofi.com%2F&amp;esheet=54255917&amp;newsitemid=20250516502271&amp;lan=en-US&amp;anchor=SoFi+Technologies%2C+Inc.&amp;index=1&amp;md5=3cc8f6a151ed26659557d2f9b94039a4">SoFi Technologies, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) has teamed up with five-time GRAMMY&#xAE; Award nominated, multiple ACM and CMA Award winning, multiplatinum songwriter, producer, and author Kelsea Ballerini and <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.tnachieves.org%2F&amp;esheet=54255917&amp;newsitemid=20250516502271&amp;lan=en-US&amp;anchor=tnAchieves&amp;index=2&amp;md5=14e56c6b22f558b6d510885ec4cdc031">tnAchieves</a>, a nationally recognized nonprofit dedicated to college access and success, to launch the Rising Stars Program. This $2 million initiative is aimed at helping the next generation of Tennessee students achieve financial independence. SoFi will provide tnAchieves with over $500,000 in grants to expand its COMPLETE program. SoFi's contributions will fund students' 1:1 coaching and financial support as they prepare for a high-skill, high-wage career, as well as a specialized financial readiness curriculum for the 60,000 students across their programs. In addition, to help people start investing early, SoFi is offering every Tennessee resident between 18-24 the opportunity to receive a minimum of $5 in stock of their choosing, at no cost, with a chance to receive up to $1,000 in stock – all with no minimum deposit or fees required.

SOFI

SoFi Partners With Kelsea Ballerini And tnAchieves To Invest $2M For Tennessee's Next Gen Students To Achieve Financial Independence

<ul>
<li>Significant functional benefits for 8- and 9-year-olds with Duchenne in Part 2 of the EMBARK study, contributing to the evidence of stabilization or slowing of disease progression in later childhood when muscle weakness typically progresses</li>
<li>Statistically significant differences were observed on all key endpoints including 4.75 points (P=0.0026) on North Star Ambulatory Assessment (NSAA), 6.87 seconds in time-to-rise (TTR) from the floor (P=0.0010), and 4.76 seconds in 10-meter walk/run (10MWR) (P=0.0097) compared to a well-matched external control cohort
<ul>
<li>Five abstracts, including two oral presentations at American Society of Gene &amp; Cell Therapy Conference, span Sarepta's portfolio of approved and pipeline therapies across Duchenne and limb-girdle muscular dystrophy</li>
</ul>
</li>
</ul>

Events

Sarepta Therapeutics Presents Part 2 EMBARK Data At American Society of Gene & Cell Therapy Conference

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

MicroCloud Hologram Announces Development Of A Neural Network-Based Quantum-Assisted Unsupervised Data Clustering Technology

Bon Natural Life Limited Announces Cooperation Agreement With Beijing Huahai Keyuan, Which Wil Serve As Exclusive Sales Partner Of BON's Postbiotic Hypoglycemic Ingredient Product Series

Press Releases

Outset Medical Announces Resolution of Warning Letter

Earnings

Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference

Outset Medical Announces One-for-Fifteen Reverse Stock Split

Legal

Alert to Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra LifeSciences Holdings Corporation (NASDAQ: IART); Outset Medical, Inc. (NASDAQ: OM); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Is Investigating Claims on Your Behalf

Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Comments

Outset Medical

ニュース

最新ニュース Outset Medical (NASDAQ:OM) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル